Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer.
Adv Radiat Oncol
; 7(2): 100857, 2022.
Article
en En
| MEDLINE
| ID: mdl-35387421
Texto completo:
1
Colección:
01-internacional
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Adv Radiat Oncol
Año:
2022
Tipo del documento:
Article